CSF1R and benign prostatic hyperplasia: Consistently, in our validation cohort comprising 16 normal prostate samples and 80 BPH samples, mRNA expression analysis of the nine sunitinib target genes revealed that only CSF1R was significantly upregulated in BPH tissues, whereas no significant differences were observed for the other eight genes between the two groups (Fig. S3a).